Figure 2
From: Intratumor heterogeneity inferred from targeted deep sequencing as a prognostic indicator

Tumor heterogeneity measurement from cancer panel sequencing of colorectal cancer. (a) Histogram and distribution of tumor heterogeneity (TH) indices. (b) Survival plot comparing patients with high and low tumor heterogeneity. (c) Differences in TH indices based on pathological stage (I, II, III, and IV). (d) Progression-free survival curves according to TH in stages I/II/III, or IV.